Children's cancer services

At a public meeting on 14 March 2024, NHS England selected Evelina London Children's Hospital as the future location for very specialist cancer treatment services for children living in south London and much of south east England.

Throughout the NHS England-led process we have provided detailed evidence to show how Evelina London is best placed to provide high quality care, research and support to children and young people with cancer.

Bringing together staff from the current Principal Treatment Centre, including the world-renowned team from The Royal Marsden, with the many specialist teams at Evelina London who already care for children with complex medical conditions, will provide joined up and innovative care for children with cancer, in family-friendly facilities.

We remain fully committed to working with patients, their families, staff from the current service, and other partners to design the new service with children, young people and staff at its heart, to ensure continuity of care during the transition period and to agree a plan for the transfer of the service.

You can read more about this decision on the NHS England website.

Watch a film about Evelina London’s plans for children's cancer services

Our Medical Director, Dr Sara Hanna, explains more about the services Evelina London currently provides and our vision for the future children's cancer service in south London and south east England 

Watch a video addressing some of the frequently asked questions about the future children’s cancer service

Our Medical Director, Dr Sara Hanna, answers frequently asked questions about the move of the children's cancer PTC.

Why Evelina London for children's cancer care

We believe we're uniquely placed to provide the best care, research and support to children and young people with cancer, and their families.

World-class

Evelina London is the only option that will mean the new children’s cancer services are based at a dedicated children's hospital. This will align our region with the rest of the country and international best practice, making sure that children and their families have access to the best possible clinical expertise. 

Clinical research

We can immediately begin new children's cancer clinical research studies and offer the latest immune therapies (like CAR-T), both essential for the future of children's cancer care. We have 2 dedicated children’s research wards and a specialist children’s research team already working on more than 180 children’s research studies with academic partners worldwide.

Family support

We understand how tough it is to be the family member of a seriously unwell child.

To support families, we'll offer:

  • free, dedicated parking for the new children’s cancer centre (matching the capacity at the current centre)
  • support with the cost of travel
  • free bedside overnight accommodation in most areas, including 60 rooms in our dedicated Ronald McDonald House for longer stays

Connected

Our children's intensive care ambulance service looks after some of the sickest children in south east England, making sure they are in the right place to receive the highly specialist care they need. We also deliver over 1,000 clinics a year in local hospitals, bringing our specialist expertise closer to where children live. Our clinical education team help to train staff at every other hospital in the region.

Evelina London Children's Hospital is an award-winning, outstanding rated hospital that has been co-designed by children and families to be bright, friendly, and offer plenty of places to play.

Thank you for taking the time to learn more about our wonderful children's hospital and our vision for the future of children's cancer care in south London and most of south east England. 

Background

On 21 June 2023, NHS England published an update on proposed new locations for a principle treatment centre for children's cancer services for south London and most of south east England. It sets out how children’s cancer services should be organised and delivered across the country in the future. Among other things, it requires all children’s cancer principal treatment centres to be on the same site as a paediatric intensive care unit (PICU) and other specialised children’s services such as paediatric surgery relevant to children’s cancer care.

Currently, the children's cancer principal treatment centre covering the catchment area of south London and most of south east England is provided by The Royal Marsden NHS Foundation Trust and and some children may also receive care at St George’s Hospital in Tooting. The Royal Marsden does not have a paediatric intensive care unit on-site, which means that some children are currently safely transferred between The Royal Marsden and St George's Hospital every year.

These arrangements need to change to make sure that children with cancer continue to get world-leading care in London.

Options appraisal process

Evelina London Children’s Hospital, which is part of Guy's and St Thomas' NHS Foundation Trust, and St George's University Hospitals NHS Foundation Trust both submitted proposals to become the new children's cancer Principal Treatment Centre, providing all the required services on one site.

Over 30 experts, including clinical advisers, parents, charities, nurses and research staff, evaluated the proposals as part of an options appraisal process designed by NHS England – London and shaped by a range of stakeholders. They looked at different aspects of the proposals to understand:

  • how the proposals would deliver the service in the future, compared to what happens currently
  • what each would mean for patients, families and staff delivering clinical care
  • how the proposals would deliver the clinical aspects of care
  • how the proposals would support research that underpins future improvement

Evelina London scored higher overall and in 3 out of the 4 areas assessed, including how we would deliver the clinical service and our capability and track record for vital clinical research. Evelina London is the preferred option at this stage in the process.

Public consultation by NHS England

A public consultation was launched by NHS England on Tuesday 26 September and ran until Monday 18 December 2023. NHS England received 2,669 formal responses which have been analysed and the findings have now been published. Read the consultation report.

NHS England's decision

On Thursday 14 March 2024 leaders for NHS England (London and South East regions) selected Evelina London Children's Hospital to be the future location of the Principal Treatment Centre for children's cancer services. 

We are fully committed to working with patients, their families, staff from the current service, and other partners to design the new service with children, young people and staff at its heart, and to ensure continuity of care during the transition period.

More information

For more information about the future children's cancer services visit the NHS England website.

Our frequently asked questions page has more information about our plans for the future children's cancer services.

Read more about our plans (Word 258KB).

If you would like to contact us please email ELCHEngagement@gstt.nhs.uk.

Find out more

Our frequently asked questions page has more information about our plans for future children's cancer services.

Find out more about the children's cancer service plans on the NHS England website.

See the Trust's official response to the consultation.

Read our blogs

  • Read about how our cardiology experts cared for Annabelle as she experienced complications with her heart during her cancer treatment.
  • Sujeev is a consultant in paediatric cardiology, running cardiac clinics for children with cancer.
  • Gráinne is an advanced nurse practitioner in our kidney transplant team. 
  • Ming is a paediatric neurologist who makes sure Evelina London continues to have the highest level of participation in research.  
  • Sue is a play specialist manager. Learn how her team support children and young people visiting our hospital and using our services.